Principles for Just Prioritization of Expensive Biological Therapies in the Danish Healthcare System.
Expensive therapies
Healthcare system
Justice
Principles
Prioritization
Journal
Journal of bioethical inquiry
ISSN: 1872-4353
Titre abrégé: J Bioeth Inq
Pays: Netherlands
ID NLM: 101250741
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
07
05
2022
accepted:
18
02
2023
medline:
6
11
2023
pubmed:
21
9
2023
entrez:
21
9
2023
Statut:
ppublish
Résumé
The Danish healthcare system must meet the need for easy and equal access to healthcare for every citizen. However, investigations have shown unfair prioritization of cancer patients and unfair prioritization of resources for expensive medicines over care. What is needed are principles for proper prioritization. This article investigates whether American ethicists Tom Beauchamp and James Childress's principle of justice may be helpful as a conceptual framework for reflections on prioritization of expensive biological therapies in the Danish healthcare system. We present an empirical study exploring the principles for prioritizing new expensive biological therapies. This study includes qualitative interviews with key Danish stakeholders experienced in antibody therapy and prioritizing resources for expensive medicines. Beauchamp and Childress's model only covers government-funded primary and acute healthcare. Based on the interviews, this study indicates that to be helpful in a Danish context this model should include equal access for citizens to government-funded primary and acute healthcare, costly medicine, and other scarce treatments. We conclude that slightly modified, Beauchamp and Childress's principle of justice might be useful as a conceptual framework for reflections on the prioritization of expensive biological therapies in the Danish healthcare system.
Identifiants
pubmed: 37733175
doi: 10.1007/s11673-023-10283-2
pii: 10.1007/s11673-023-10283-2
pmc: PMC10624754
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
523-542Informations de copyright
© 2023. The Author(s).
Références
Med Health Care Philos. 2002;5(3):235-44
pubmed: 12517031
J Biomed Sci. 2020 Jan 2;27(1):1
pubmed: 31894001
Ann Rheum Dis. 1999 Nov;58 Suppl 1:I129-30
pubmed: 10577989
Health Care Anal. 2017 Mar;25(1):1-20
pubmed: 25145639
Health Care Anal. 2017 Mar;25(1):21-33
pubmed: 27734213
Annu Rev Pharmacol Toxicol. 2015;55:191-206
pubmed: 25149920
Med Health Care Philos. 2007 Mar;10(1):33-48
pubmed: 16955345
J Med Ethics. 2022 Feb;48(2):86-92
pubmed: 34815319
J Med Ethics. 2022 Sep;48(9):624-628
pubmed: 34103369
Neurotherapeutics. 2017 Oct;14(4):1018-1026
pubmed: 28812229
J Law Med Ethics. 2020 Sep;48(3):579-582
pubmed: 33021187
Front Immunol. 2022 Sep 12;13:953649
pubmed: 36172350
Nat Rev Immunol. 2020 Feb;20(2):75-76
pubmed: 31925406
Bioethics. 2021 May;35(4):307-314
pubmed: 33107077
BMJ. 2000 Jan 1;320(7226):50-2
pubmed: 10617534
Med Health Care Philos. 2010 Aug;13(3):237-46
pubmed: 20306307
J Law Med Ethics. 2020 Sep;48(3):567-578
pubmed: 33021191
Philos Ethics Humanit Med. 2007 Oct 25;2:23
pubmed: 17961251
Scand J Caring Sci. 2004 Jun;18(2):145-53
pubmed: 15147477